Poseida Therapeutics Inc banner

Poseida Therapeutics Inc
F:2RZ

Watchlist Manager
Poseida Therapeutics Inc Logo
Poseida Therapeutics Inc
F:2RZ
Watchlist
Price: 9.05 EUR Market Closed
Market Cap: €877.5m

Wall St Price Targets

2RZ Price Targets Summary
Poseida Therapeutics Inc

There are no price targets for 2RZ.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Poseida Therapeutics Inc Competitors:
Price Targets
AREC
American Resources Corp
166% Upside
SMCP
SMCP SA
79% Upside

Revenue
Forecast

67% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
32%
Average Beat
67% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
32%
Average Beat

Over the last 6 years, the compound annual growth rate for Revenue has been 67%. The projected CAGR for the next 4 years is 13%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 2RZ's stock price target?
Not Available

2RZ does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Poseida Therapeutics Inc?
Projected CAGR
13%

Over the last 6 years, the compound annual growth rate for Revenue has been 67%. The projected CAGR for the next 4 years is 13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett